Related Experiment Video
Updated: Mar 14, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome
Thomas M Kaffenberger1, Rajarsi Mandal2, Barry M Schaitkin3
1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, U.S.A.
Abstract:
Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199-1201, 2017.
Insights
Forced eyelid closure syndrome (FECS) causes objective tinnitus. Intrapalatal botulinum toxin successfully treated a patient with FECS, resolving tinnitus symptoms.
Area of Science:
- Neurology
- Otolaryngology
- Ophthalmology
Background:
- Objective tinnitus linked to eyelid closure is rare, previously termed forced eyelid closure syndrome (FECS).
- FECS involves aberrant neural reflexes between cranial nerves VII and V.
Observation:
- A 52-year-old female presented with a 2-month history of FECS.
- Symptoms included objective tinnitus associated with eyelid closure.
Findings:
- The patient received intrapalatal botulinum toxin treatment.
- This intervention resulted in the full resolution of objective tinnitus symptoms.
Implications:
- This case represents the first reported use of botulinum toxin for FECS.
- Botulinum toxin may be a viable treatment option for objective tinnitus in FECS.
More Related Videos
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Direct-Acting Cholinergic Agonists: Therapeutic Uses

